Volvo Faces XL Regulatory Risk as XC Sales Surge — Panjiva


Volvo Faces XL Regulatory Risk as XC Sales Surge

China 1758 Cons. Discr. - Autos 661 European Union 406 Sweden 12 Tariffs 1169 U.S. 3297

Volvo Cars delivered a 15% growth in sales in July vs. a year earlier including a 24% surge in deliveries in the U.S. That was helped by sales of its XC-series SUV which came as sales of imported trucks dominated wider sales growth in the U.S. The challenge comes in that part of the XC range is assembled in China and therefore faces 25% duties under the U.S. section 301 review as well as the section 232 review of the industry more broadly. Volvo’s U.S. imports from China, including the XC70 and S90 sedan, rose 9% on a year earlier to hit a record in anticipation of the duties. The exempt...

PANJIVA RESEARCH is a service provided by Panjiva, Inc. ("Panjiva") to relevant global subscribers, and are deemed to be Panjiva "Services" subject to the Panjiva Terms & Conditions of Use. Information contained within or made available via the Services is for informational purposes only and nothing in the Services shall constitute or be construed as an offering of financial instruments, or as investment advice or recommendations by Panjiva, Inc. or its affiliates of an investment strategy or whether to "buy", "sell" or "hold" an investment. The Services may include views and commentary about customers of Panjiva. No aspect of the Services is based on consideration of your individual circumstances, and you should determine on your own whether you agree with the information contained within or made available via the Services. Employees involved in Panjiva Research may hold positions in securities analyzed or discussed in the Services. Panjiva does not make any express or implied warranties, representations, endorsements or conditions with respect to the Services and the information contained within or made available via the Services, including without limitation, warranties as to the usefulness, completeness, accuracy, currentness, reliability or sufficiency of any information (including, without limitation, conclusions, statements, opinions, estimates, forecasts or projections of any kind) and expressly disclaims any implied warranties. Neither this disclaimer nor any of its contents may be forwarded or redistributed without the prior written consent of Panjiva. © 2019 Panjiva, Inc. All Rights Reserved.